Clinical Features Time to Death AGE PRIMARY.SITE.OF.DISEASE NEOPLASM.DISEASESTAGE PATHOLOGY.T.STAGE PATHOLOGY.N.STAGE PATHOLOGY.M.STAGE GENDER HISTOLOGICAL.TYPE COMPLETENESS.OF.RESECTION NUMBER.OF.LYMPH.NODES nMutated (%) nWild-Type logrank test_P logrank test_Q t-test_P t-test_Q Fisher's exact test_P Fisher's exact test_Q Chi-square test_P Chi-square test_Q Fisher's exact test_P Fisher's exact test_Q Fisher's exact test_P Fisher's exact test_Q Fisher's exact test_P Fisher's exact test_Q Fisher's exact test_P Fisher's exact test_Q Fisher's exact test_P Fisher's exact test_Q Fisher's exact test_P Fisher's exact test_Q t-test_P t-test_Q APC 160 (72%) 63 0.49992 1 0.29285 1 0.023215 1 0.95327 1 0.945 1 0.86512 1 0.60878 1 0.05306 1 0.12806 1 0.18638 1 0.89904 1 FBXW7 38 (17%) 185 0.97698 1 0.062277 1 0.33953 1 0.056072 1 0.11677 1 0.7448 1 0.0035548 0.889 0.37448 1 0.031642 1 0.034608 1 0.8548 1 NRAS 20 (9%) 203 0.14504 1 0.039128 1 0.62254 1 0.41445 1 0.29227 1 0.036605 1 0.54168 1 0.035749 1 1 1 0.4708 1 0.025125 1 BRAF 22 (10%) 201 0.66655 1 0.090195 1 0.026116 1 0.15358 1 0.079853 1 0.90428 1 0.39472 1 0.070287 1 9.6052e-06 0.00245 0.61188 1 0.58929 1 KRAS 96 (43%) 127 0.033772 1 0.14102 1 0.027248 1 0.73938 1 0.29648 1 0.29147 1 0.17237 1 0.59096 1 0.085596 1 0.036473 1 0.19432 1 TP53 119 (53%) 104 0.48534 1 0.077823 1 0.013043 1 0.34367 1 0.92771 1 0.2582 1 0.88529 1 0.28525 1 0.00016408 0.0415 0.5661 1 0.42982 1 SMAD4 26 (12%) 197 0.61262 1 0.95103 1 1 1 0.97045 1 0.87004 1 1 1 0.79624 1 0.83792 1 0.01426 1 0.83076 1 0.31776 1 FAM123B 25 (11%) 198 0.80095 1 0.89578 1 0.49864 1 0.88845 1 0.70475 1 0.31608 1 0.7817 1 1 1 0.8562 1 0.64592 1 0.49811 1 PIK3CA 33 (15%) 190 0.92523 1 0.096642 1 0.22555 1 0.020238 1 0.91612 1 0.021971 1 0.13285 1 0.85091 1 0.029681 1 0.30371 1 1.2631e-05 0.00321 SMAD2 15 (7%) 208 0.98045 1 0.68883 1 0.77967 1 0.0026714 0.671 0.37297 1 0.27022 1 1 1 0.2911 1 0.37954 1 0.74783 1 0.034067 1 TCF7L2 18 (8%) 205 0.24278 1 0.38535 1 0.78504 1 0.86513 1 0.3371 1 0.9432 1 0.73651 1 0.62442 1 0.48131 1 0.57504 1 0.10839 1 ACVR2A 9 (4%) 214 0.21711 1 0.44347 1 0.2809 1 0.49189 1 0.90502 1 0.35262 1 1 1 0.091162 1 0.70355 1 1 1 3.9898e-08 1.03e-05 SOX9 10 (4%) 213 0.68044 1 0.27395 1 0.18095 1 0.30906 1 0.15472 1 0.9017 1 1 1 0.52611 1 0.60782 1 1 1 0.20326 1 ELF3 6 (3%) 217 0.61636 1 0.197 1 0.37482 1 0.97387 1 0.2048 1 1 1 1 1 0.68479 1 0.83086 1 0.59506 1 0.62587 1 CRTC1 6 (3%) 217 NA NA 0.035369 1 0.66914 1 0.26564 1 0.2048 1 0.53551 1 0.60913 1 0.43038 1 0.74533 1 1 1 0.00047298 0.119 TNFRSF10C 6 (3%) 217 NA NA 0.85371 1 0.18071 1 0.33653 1 0.071182 1 0.19547 1 0.064008 1 0.68479 1 0.42319 1 0.079905 1 0.18406 1 KIAA1804 15 (7%) 208 0.25128 1 0.77966 1 0.018067 1 0.84331 1 0.73218 1 0.34473 1 1 1 0.42534 1 0.022286 1 0.74783 1 0.012933 1 KRTAP5-5 4 (2%) 219 NA NA 0.91203 1 0.5885 1 0.026252 1 0.43133 1 0.47887 1 1 1 1 1 0.77306 1 1 1 3.2089e-11 8.31e-09 PTEN 7 (3%) 216 0.48994 1 0.029245 1 0.67899 1 0.24696 1 0.17511 1 1 1 1 1 0.71275 1 0.22336 1 0.59506 1 0.13969 1 ACOT4 3 (1%) 220 NA NA 0.027111 1 0.55444 1 0.98618 1 0.064231 1 1 1 0.37597 1 1 1 0.3789 1 0.36148 1 0.65258 1 MYO1B 13 (6%) 210 0.3176 1 0.61087 1 1 1 0.26307 1 0.68315 1 0.53036 1 0.26653 1 0.77777 1 0.30801 1 0.45823 1 0.12289 1 PCBP1 6 (3%) 217 0.54137 1 0.77712 1 1 1 5.5249e-06 0.00141 0.5075 1 0.53551 1 0.031066 1 0.68479 1 1 1 1 1 0.012858 1 GGT1 3 (1%) 220 NA NA 0.95746 1 0.55444 1 0.92865 1 0.70371 1 0.56675 1 1 1 0.60861 1 0.71544 1 1 1 3.2428e-11 8.37e-09 ACVR1B 14 (6%) 209 0.77537 1 0.80864 1 0.069183 1 0.26819 1 0.039663 1 1 1 0.7173 1 1 1 0.020976 1 1 1 0.4768 1